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Abstract 
 
Objective: To evaluate the impact of a multi-disciplinary back pain rehabilitation programme 
using a combination of individual and group change data.  Methods: 261 consecutive patients 
attending assessment for the programme completed the SF-36 questionnaire.  Questionnaires 
were repeated at programme completion and at 6-month follow-up.  Reliable Change Index 
was used to define ‘clinical significance’ to assess individual change.  Results: Half of those 
considered suitable for the programme subsequently completed it.  In group terms, non-
completers scored lower than completers on all SF-36 scales. Statistically significant 
improvements were evident for those completing the programme (all scales at p< 0.000), with 
improvement maintained at follow-up.  In individual terms, ‘clinical significance’ was 
exceeded most frequently in Physical Functioning and Role Physical scales.  Whilst some 
participants lost previous improvements between completion and follow-up, others improved 
over this time period. The majority of those completing the programme showed improvement 
in at least one scale.  Conclusions: Adding assessment of individual change to traditional 
group change measures provides greater insight into the impact a rehabilitation programme 
has upon participants’ quality of life.  Whilst the programme is clearly effective for those 
who complete it, work is required to limit post programme deterioration and improve uptake. 
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Abbreviations 
PF – Physical Functioning 
RP – Role Physical 
BP – Bodily Pain 
GH – General Health 
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CS-PF – Clinically significant improvement in physical functioning 
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Introduction 
Low back pain remains one of medicine’s most enigmatic problems, particularly in its 
chronic form.  The majority of people will experience back pain at some point in their lives 
[1], but only a minority will receive a positive diagnosis [2,3].  Most will receive what are 
often perceived as vague diagnoses such as “mechanical back pain” or “non-specific low 
back pain”.  These apparently benign labels however, hide a health problem that costs society 
more than cancer, coronary artery disease and AIDS combined [4].  The cost of this 
“epidemic” [5] has spurred much debate amongst researchers, therapists and clinicians alike, 
with a common aim of defining effective treatment regimes.  Bio-medical approaches have 
tended to be replaced by more ‘holistic’ bio-psychosocial approaches [6] and indeed, some 
have argued that it is best not to view chronic back pain as a ‘medical’ problem at all [7].  
There is certainly no one therapeutic ‘silver bullet’ and therefore increasingly back pain is 
treated as a multi-disciplinary problem.   
 
Rehabilitation programmes tend to be built around the proven effectiveness of cognitive 
behavioural approaches [8, 9, 10] and exercise [11, 12].  They are typically delivered by 
multi-disciplinary teams.  A review by Guzman et al. [13] showed the effectiveness of multi-
disciplinary programmes, but a Cochrane Review [14] cautioned that many studies had 
methodological shortcomings.  Some have also questioned the cost-effectiveness of such 
programmes [15].  Whilst the content of multi-disciplinary programmes can vary [16], the 
evidence base is sufficient for them to be considered the preferred choice for chronic non-
specific back pain within recent clinical guidelines [17, 18]. 
 
One such multi-disciplinary programme is the ‘Nottingham Back Team’ - a rehabilitation 
programme, utilising a team of staff with nursing, physiotherapy, occupational therapy and 
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clinical psychology skills.  The team takes a cognitive behavioural approach based on a 
programme of education, goal setting, support and exercise.  This paper describes an analysis 
of SF-36 data gathered within the programme immediately after its inception.  It seeks to 
evaluate the impact of the programme on participants health ‘profile’ and the degree to which 
improvements were maintained at six month follow-up.  In addition it aimed to identify any 
health differences between those completing the programme and those who either failed to 
attend or dropped-out after 2-3 weeks (which is relatively common).  Following the approach 
described by Ferguson et al [19], reliable Change Index was used to gauge ‘clinical 
significance’ and allow analysis of individual scores in addition to group comparisons.  
 
Materials and Methods 
 
Patients and methods 
Patients referred for assessment to the Back Team programme completed a questionnaire 
battery (including SF-36) prior to a physical examination and face-to-face consultation. The 
questionnaire battery was also administered at programme completion (at the end of the final 
session) and at six-month follow-up.  Consent for use of the questionnaire data was obtained 
at the assessment visit. 
 
The Nottingham Back Team was set up in 2000, in response to the Clinical Standards 
Advisory Group Report [20], and lengthy local waiting times for consultation at the spinal 
unit [21].  The programme is of fixed duration, consisting of seven three-hour sessions 
(morning or afternoon) on consecutive weeks.  The sessions are held at local leisure centres 
within the community, rather than being hospital based.  Each session has four key 
components: 
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 Group education, covering a different topic each week (e.g. types of medication) 
 Group exercise – this varies from week to week, but with a core set of 
stretches/exercises on which participants track their progress (individuals are also 
provided with a tailored exercise programme to perform at home). 
 Relaxation training – after the exercise session, participants are taught a relaxation 
technique each week 
 Key worker – each participant has a designated key worker for the duration of the 
programme.  On an individual basis, participants discuss their progress during the 
previous week and define goals for the following week. 
 
In addition to the group sessions, participants have access (if required) to specialist support in 
relation to medication issues, cognitive behavioural therapy, vocational guidance and 
psychological assessment.  Whilst the programme is of fixed duration, patients are offered an 
‘open appointment’ for one year should they need additional support or advice following the 
programme. 
 
The SF-36 Health Survey [22] is one of the most widely used health and quality of life 
measures. It’s thirty six items measure eight multi-item variables: physical functioning (PF); 
role limitation due to physical problems (RP); bodily pain (BP); general health (GH); vitality 
(VT); social functioning (SF); role limitation due to emotional problems (RE); and mental 
health (MH).  Version 2 of the SF-36 has been designed to facilitate norm-based scoring for 
all scales [23].  Raw scores are first transformed into 0-100 scores before being further 
transformed in to T-scores where the mean is fixed as 50 (the population norm) and the 
standard deviation is 10. 
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Statistical Analysis 
SF-36 data were analysed in terms of statistical significance (change within and between 
groups); with reference to the SF-36 scoring manual [23], which provides tables of sample 
sizes needed to detect particular differences over time; in relation to UK norms (T-scores); 
and utilising Reliable Change Index (RCI) scores to assess ‘clinical significance’ (meaningful 
individual change).   
 
The majority of reported studies using SF-36 describe analysis with parametric statistics [24].  
It has been argued that non-parametric methods should be used [25] as the distributions tend 
to be skewed, but in reality, the use of parametric tests is unlikely to produce misleading 
results provided samples are not small [24, 26].  When distributions are skewed however, 
non-parametric methods can provide greater statistical power than parametric equivalents 
[27, 28, 29].  For this reason, group differences were analysed using Wilcoxon signed ranks 
(changes over time) and Mann Whitney U (between groups differences).   
 
A number of methods are available to assess statistically significant individual change [30] 
and clinical significance/meaningful change [31].  Ferguson et al [19] describe the use of 
Reliable Change Index with SF-36 data and the approach they used has been adopted within 
this study, but using relevant UK norm data [32, 33].  Clinical significance is taken as a 
change exceeding the RCI value which also results in the final score falling within the 
‘normal range’ [19].  The cut-off defining ‘normal range’ can be taken as one, one and a half 
or two standard deviations from the norm [19].  The choice of cut-off will depend on the 
situation in question, but much of the literature on Reliable Change Index uses two standard 
deviations for studies in mental health [34]. 
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Results 
A total of 261 patients provided usable SF-36 questionnaires.  104 patients went on to 
complete the programme, whereas 112 failed to attend at all or failed to complete the 
programme.  The remainder were unsuitable for the programme – unsuitability could be due 
to the nature of their condition (requiring alternative treatments), their level of disability 
(precluding participation in exercise elements), or ‘logistical’ problems such as inability to 
organise child care.  Of the 104 completing the programme, 73 provided follow-up data at 6 
months. 
 
The ‘health profile’ of those considered suitable for the programme is illustrated in Figure 1.  
The relationship to UK norms is illustrated as this figure uses data transformed to T scores 
with mean of 50 (equivalent to UK norm) and standard deviation of 10. 
 
Figure 1 approximately here 
 
The sample at assessment was 50% female.  Age distribution was similar between genders - 
mean age of female participants was 43.8 years (SD 13.83) and the mean age of male 
participants was 44.5 years (SD 13.92).  The even gender split was maintained at programme 
completion, but not at follow-up.  At follow-up, the sample was 57% female. 
 
Comparison of patients completing the programme with those who declined/dropped out 
When comparing completers and non-completers, significant differences can be seen in each 
of the eight SF-36 scales.  Differences are described in Table 1. 
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Table 1 approximately here 
 
Changes in those completing the programme 
For those completing the programme, significant improvements are evident on each scale (all 
p < 0.000).  The SF-36 manual provides tables of sample sizes required to identify given 
changes in scores – from these tables, sample sizes are clearly large enough given the size of 
changes observed.  The changes in Physical Functioning and Role Physical scores exceed 
RCI values.  The changes are summarised in Table 2. 
 
Table 2 approximately here 
 
Figure 2 illustrates the change in health profile as a result of the programme – again, T-values 
are used to facilitate comparison with UK norms. 
 
Figure 2 approximately here 
 
For those attending the six-month follow-up, no significant group differences are evident, for 
any scale, between scores at programme completion and scores at follow-up. 
 
Gender differences were evident at assessment, programme completion and follow-up.  At 
assessment there was a difference in Role Physical (p<0.05).  At programme completion 
there were differences in Bodily Pain (p<0.05) and Social Functioning (p<0.05).  At follow-
up there were differences in Bodily Pain (p<0.01), Role Physical (p<0.05), Social 
Functioning (p<0.05) and Role Emotional (p<0.05).  In each case, the female scores exceeded 
male scores. 
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Individual Level 
Table 3 shows the proportion of participants who completed the programme who showed 
‘clinically significant’ improvements (i.e. exceeding RCI values) in each of the SF-36 scales. 
 
Tables 3 approximately here 
 
For those participants attending the six-month follow-up appointment, Table 4 provides an 
overview of clinically significant changes for three time periods – assessment to programme 
completion; programme completion to six-month follow-up; and assessment to six month 
follow-up.  For the period programme completion to six month follow-up, there were 
clinically significant declines as well as improvements.  There were no clinically significant 
declines for the other two time periods.  
 
Table 4 approximately here 
 
Table 5 describes the extent of clinically significant, concurrent improvement in SF-36 
scales.  It describes the proportion of those participants showing a clinically significant 
improvement between assessment and six-month follow-up in each of the SF-36 scales who 
also showed a clinically significant improvement in each of the other 7 scales over the same 
period. 
 
Table 5 approximately here 
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Table 6 describes mean scores at assessment for each of the eight SF-36 scales for the whole 
sample and three important sub-groups – those who showed at six-month follow-up:  
 significant reduction in disability (physical functioning) 
 significant improvement in perceived functional limitation (role physical) 
 significant reduction in pain and related limitations (bodily pain) 
 
It illustrates differences between the whole sample (all those considered suitable for the 
programme), and those that showed clinically significant improvement between assessment 
and follow-up in physical functioning (CS-PF); role physical (CS-RP); and bodily pain (CS-
BP).  None of the differences were statistically significant however. 
 
Table 6 approximately here 
 
Considering those that attended at follow-up, only 1 participant showed no clinically 
significant change on any scale over any of the time periods involved in the study. 
 
Of the follow-up group, 93% of participants showed clinically significant improvement 
between assessment and follow-up on at least one scale. 
 
Discussion 
This study sought to evaluate the impact of a rehabilitation programme on patients’ health 
profile, the degree to which any improvements were maintained over time and to explore 
differences between those that completed the course and those that chose not to.  The study 
utilised both individual and group scores in its analysis of an SF-36 data set.  Whilst this is 
relatively unusual, both approaches are required in interpreting clinical significance in 
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quality-of-life data [35].  Just as taking different statistical approaches to data analysis can 
alter the emphasis of results [36], using individual assessment alongside more familiar group 
comparisons allows a different perspective to be taken on the data.  Individual assessment 
criteria also allow for the definition of sub-groups which may prove useful in clinical 
practice, by facilitating more tailored treatment regimes [37]. 
 
A number of methods are available for evaluating significant change at an individual level.  
Hays et al [30] describe the use of the standard error of measurement and the standard error 
of prediction alongside RCI.  The paper emphasises the point that whichever measure is used, 
changes required to be significant at an individual level are much greater than those required 
at a group level.  Indeed if samples are large enough, quite small group-level changes may be 
statistically significant, but essentially meaningless in clinical terms.  Whilst different 
techniques will provide different results [31], there does appear to be a reasonable 
comparability between approaches [38, 39] which is supportive of the construct as a whole.  
Whilst no single approach is likely to be uniformly accepted [40] and ‘blindly’ following a 
single threshold value could be misleading [41], the emerging evidence is supportive of the 
view that ‘clinical significance’ is an important element in the evaluation of treatment 
effectiveness. 
 
Using Reliable Change as an evaluation criterion was first suggested over 20 years ago [42] 
and the technique was described in detail by Jacobson and Truax in 1991 [43].  Since then it 
has been increasingly used in fields such as psychotherapy, but is much less common in 
medical outcomes research [19].  The concept of defining a minimum criterion for ‘clinically 
significant’ change is not new in disability or rehabilitation research however.  For instance, 
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it is widely accepted that a change of less that 2.5 points on the Roland-Morris Disability 
Questionnaire should not be seen as ‘clinically significant’ [44, 45]. 
 
Ferguson et al [19] describe the application of RCI to SF-36 outcomes and the approach they 
defined has been taken in this study, but with RCI criteria calculated using relevant UK data 
from the Health Services Research Unit at the University of Oxford [32, 33].  Whilst any 
particular defined change value can be said to be somewhat arbitrary, reliable change index is 
a conservative measure [35].  SF-36 is itself a robust tool [22] and its scales are associated 
with low back pain outcome measures [46], so combining the two should prove effective 
even if it may tend to underestimate the impact of treatment. 
 
Both the assessment and post-programme groups showed an even gender split.  Previous 
studies have shown differences in pain perception and associated behaviours between genders 
[47, 48] which have been explained in terms of psychological, physiological and socio-
cultural factors.  Similar differences have been described for treatment outcomes [49, 50].  In 
this study, gender differences were identified in four SF-36 scales – Role Physical, Bodily 
Pain, Social Functioning and Role Emotional.  In each case male participants scored lower 
than their female counterparts.  This is the opposite of most previous research where females 
tend to report higher pain levels [51].  The reasons for this anomaly are unclear, but it appears 
that female patients respond well to this programme, with proportionately more females 
showing clinically significant improvement in physical functioning and bodily pain. 
 
Predictably, when considering the health profile of those assessed and suitable for the Back 
Team programme, lowest scores are seen in physical functioning, role physical and bodily 
pain.  Each of these scales falls greater than one and a half standard deviations from the 
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norm.  The only other scale falling further than one standard deviation from the norm is 
Social Functioning.  The scale falling closest to the norm is Mental Health, which is within 
half a standard deviation, despite the fact that low back pain is often associated with 
psychological factors [52, 53, 54].  Indeed, the mean mental health score at programme 
completion was very slightly above UK norm.  An ongoing research project will be looking 
at these issues. 
 
When comparing scores at assessment between those that subsequently completed the 
programme and those who failed to complete, statistically significant differences can be seen 
on all scales.  The differences are relatively small however, compared to the size of change in 
response to the programme.  The scale Role Physical exceeds the RCI value.  It appears that 
failure to engage with the programme may be due to a belief amongst potential participants 
that they are too disabled by their condition to undertake a programme of this type.  This 
could reflect strong ‘organic’ pain beliefs [55], where the patient strongly believes ‘hurt = 
harm’ (a ‘biomedical’ perspective).  Patients with strong organic pain beliefs tend to have an 
external locus of control and are more likely to expect the medical practitioner to ‘cure’ them 
rather than take responsibility for themselves [55].  Further work with the programme is 
examining the nature of pain beliefs within this population.   
 
Equally, failure to engage may reflect a lack of understanding of what the programme will 
entail and some similar programmes have successfully utilised a pre-programme session to 
deal with this.  Unfortunately, resource constraints have prevented the team from gathering 
data on reasons for failure to engage with the programme.  More recently, the team has 
changed its policy such that places are not routinely allocated to those assessed as suitable for 
the programme, but rather patients are asked to explicitly ‘opt in’ to a particular group.  This 
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change has led to fuller groups, improved completion rates and reduced waiting times, but 
has not addressed the underlying issue of why some individuals fail to engage. 
 
For those completing the programme, statistically significant improvements can be seen on 
all scales.  From the SF-36 scoring manual, the sample size exceeds the ‘numbers needed’ for 
the magnitude of change.  Only two scales exceed RCI criteria – Physical Functioning and 
Role Physical.  At a group level, this programme can be said to provide clinically significant 
improvements in disability for those completing the programme. 
 
Whilst traditional statistical analysis can provide scientifically robust results, by comparing 
two distributions, little can be said about the extent to which any individual improves or 
declines.  Defining clinically significant change with RCI values allows a different 
perspective to be taken on the data.  Using this approach it can be seen that of those 
completing the programme, the scales on which most participants improve are Physical 
Functioning and Role Physical with more than half the sample showing clinically significant 
improvement.  After these scales, Bodily Pain, Social Functioning and Role Emotional show 
a similar proportion of the sample improving at around 40%.  General Health, Vitality and 
Mental Health scales show lower proportions of improvement at 23%, 32% and 28% 
respectively. 
 
Analysis of data from those attending six-month follow-up provides an understanding of 
change across three important time frames: 
 The duration of the programme – difference between assessment and programme 
completion scores  
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 Change subsequent to the programme – difference between programme completion 
score and 6-month follow-up  
 Overall, long-term change – the difference between initial assessment scores and 
those at follow-up. 
 
For six of the eight scales, more participants show a decline between programme completion 
and follow-up than an improvement, the exceptions being Vitality and Role Emotional.  The 
largest proportional decline between programme completion and follow-up occurs in the 
scales which had shown largest numbers improving from assessment to programme 
completion – physical functioning and role physical.  These figures indicate that change can 
take place in a number of ways: 
 Initial improvement, maintained at follow-up (‘early takers’) 
 Initial improvement, lost at follow-up (‘need support’) 
 No initial improvement, but improvement by follow-up (‘slow burners’) 
 No improvement at any stage (‘non-takers’) 
 
This has important implications when attempting to assess the true impact of a programme as 
those showing improvement at programme completion may not maintain that improvement 
once the support of the programme is removed.  Equally, for the ‘slow burners’, a 
rehabilitation programme may facilitate a major change in their life (the beginnings of a 
recovery) without showing a significant improvement during the course of the programme 
itself.  When considering the cost benefits of this type of programme, consideration must be 
made to the degree to which gains during the programme may be lost following its 
completion and the optimal nature of follow-up and support which may need to be better 
tailored to the needs of particular patient groups (particularly the ‘need support’ group). 
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Analysing individual change also illustrates that improvements are not seen uniformly across 
scales.  Considering ‘long-term’ change (assessment to follow-up), the scale on which the 
greatest number improved was Role-Physical, with 70% improving.  This could be said to 
reflect the cognitive behavioural aspect of the course whereby participants learn that they can 
manage their condition and that it need not control or restrict their lives.  Almost a quarter of 
those showing an improvement in Role Physical did not show a corresponding improvement 
in Physical Functioning however, suggesting that improvement in ‘perceived’ disability can 
be made without a real change in the limitation imposed by their condition.  This supports the 
view that disability is driven by psychological as well as physical factors [56, 57]. 
 
Whilst the figure of 70% is the highest score for an individual scale, this could be said to 
under-estimate the impact of the programme as 93% of those attending the six-month follow-
up showed an improvement in at least one scale (assessment to follow-up).  For the 
overwhelming majority of the participants continuing the programme through to follow-up, 
the programme can be said to have had a genuine positive effect.  Whilst some observed 
improvements at programme completion were subsequently lost by follow-up, only one 
participant failed to show a clinically significant change on any scale over any time period.  
Whilst some of the improvement may be due more to the social nature of the group 
programme than to its content, the benefits in quality of life are nevertheless important and 
‘real’.  Previous work by the lead author [58] has shown the impact of social isolation 
amongst chronic back pain sufferers and the benefits perceived within a group setting. 
 
Over a third of those showing clinically significant change in the scales Physical Functioning 
and Role Physical do not show a corresponding improvement in Bodily Pain scores.  This 
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suggests that disability can improve without a reduction in pain levels and supports previous 
research showing the lack of a uniform relationship between pain levels and disability [59].   
 
The individual scores can also be used to allow sub-groups to be defined.  By splitting the 
sample on whether they had shown a clinically significant change on a particular variable, 
clues can be sought for some predisposition to improvement.  When considering the mean 
scores at assessment for each SF-36 scale for the whole sample and those who had shown 
clinically significant improvement in Physical Functioning, Role Physical and Bodily Pain, 
little difference is evident, with the greatest differences being on the General Health scale.  
Even for this scale however, there are no statistically significant differences between those 
who subsequently show clinically significant improvement and those who do not.  Beliefs in 
relation to ‘general health’ and ‘perceived disability’ may be significant in programme 
completion however and this area warrants further research. 
 
Conclusions 
This study illustrates the benefits to be gained by analysing individual change in addition to 
group changes when evaluating the impact of a rehabilitation programme.  From both 
perspectives, the programme has greatest impact upon Physical Functioning and Role 
Physical – the two SF-36 scales relating most closely to disability. The improvement is not a 
simple linear change however as some participants show a loss of improvement at follow-up 
whilst others show an improvement by follow-up without one being evident over the duration 
of the programme itself.   
 
Equally, the study illustrates that an improvement in one scale is not necessarily associated 
with improvements on other scales – an improvement in pain is associated with an 
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improvement in disability for the vast majority of cases, but this is not true in the reverse.  
This study therefore supports the view that improving an individual’s pain score is not a pre-
requisite to addressing disability levels. 
 
The programme has widespread impact and the vast majority of participants at follow-up had 
shown clinically significant improvement in at least one scale between assessment and 
follow-up.  Whilst this is not a controlled experimental study, the data suggests that the Back 
Team Programme represents an effective intervention for those with chronic low back pain. 
 
Very few participants are unaffected by the programme, so efforts to improve its 
effectiveness should concentrate on addressing decline following the programme and in 
ensuring improvement over a wider spectrum of health factors.  Of greatest concern however 
is the proportion of those suitable for the programme who decline the opportunity.  Further 
research should explore these factors and other differences between completers and non-
completers with a goal of improving programme uptake. 
 
Acknowledgements 
The authors would like to acknowledge the generous support offered by all staff at the 
Nottingham Back Team. 
 
 20 
References 
1. Waddell G. (2004). The Back Pain Revolution. (London: Churchill Livingstone) 
2. Snook S. (2004). Work-related low back pain: secondary intervention. J Electromyogr 
Kinesiol, 14, 153-160 
3. Deyo, R. & Weinstein, J. (2001). Low back pain. N Engl J Med, 344, 363-370. 
4. Thomsen, A. Sorenson, J. Sjorgen, P. & Eriksen, J. (2002). Chronic non-malignant pain 
patients and health economic consequences.  European Journal of Pain, 6, 341-352 
5. Bruntland, G. (2000).  Scientific Group Meeting on the Burden of Musculoskeletal 
Disorders.  World Health Organisation. Retrieved August 20, 2000 from 
http://www.who.int/director-general/speeches/2000/english/20000113_bone_joint.html 
6. Borkan, J. Van Tulder, M. Reis, S. Schoene, M. Croft, P. & Hermoni, D. (2002). Advances 
in the field of low back pain in primary care: a report from the fourth international forum. 
Spine, 27, 128-132. 
7. Fordyce, W. & the International Association for the Study of Pain Task Force on Pain. 
(1995). Back pain in the workplace: management of disability in nonspecific conditions. 
(Seattle: IASP Press).  
8. Linton, S. & Ryberg, M. (2001) A cognitive-behavioral group intervention as prevention 
for persistent neck and back pain in a non-patient population: a randomized controlled trial. 
Pain, 90, 83-90. 
9. Morley, S. Eccleston, C. & Williams, A. (1999). Systematic review and meta-analysis of 
randomized controlled trials of cognitive behaviour therapy and behaviour therapy for 
chronic pain in adults, excluding headache. Pain, 80, 1-13. 
10. van Tulder, M. Ostelo, R. Vlaeyen, J. Linton, S. Morley, S. & Assendelft, W. (2000). 
Behavioral treatment for chronic low back pain: a systematic review within the framework of 
the Cochrane Back Review Group.  Spine, 25, 2688-2699. 
 21 
11. Abenhaim, L. Rossignol, M. Valat, J. Nordin, M. Avouac, B. & Blotman, F. (2000). The 
role of activity in the therapeutic management of back pain. Report of the International Paris 
Task Force on Back Pain. Spine, 25, 1S-33S 
12. Liddle, S. Baxter, G. & Gracey, J. (2004). Exercise and chronic low back pain: what 
works? Pain, 107, 176-190. 
13. Guzman, J. Esmail, R. Karjalainen, K. Malmivaara, A. Irvin, E. & Bombardier, C. (2001) 
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ, 322, 
1511-1516 
14. Karjalainen, K. Malmivaara, A. van Tulder, M. Roine, R. Jauhiainen, M. Hurri, H. & 
Koes, B. (2001).  Multidisciplinary biopsychosocial rehabilitation for subacute low back pain 
in working-age adults: a systematic review within the framework of the Cochrane 
Collaboration Back Review Group. Spine, 26, 262-269 
15. Turk, D. (2002). Chronic non-malignant pain patients and health economic consequences. 
Eur J Pain, 6, 353-355. 
16. Airaksinen, O. Brox, J-I. Cedraschi, C. Hildebrandt, J. Klaber-Moffett, J. Kovacs, F. 
Mannion, A. Reis, S. Staal, J. Ursin, H. and Zanoli, G. (2005).  Multi-disciplinary 
Interventions.  (In Cost Action B13, European guidelines for the management of chronic 
nonspecific low back pain.  European Commission Research Inspectorate General) 
17. Balague, F. Mannion, A. Pellise F. and Cedraschi, C. (2007).  Clinical update: low back 
pain.  The Lancet, 369, 726-728 
18. Chou, R. Qaseem, A. Snow, V. Casey, D. Cross, J. Shekelle, P. and Owens, D. (2007)  
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the 
American College of Physicians and the American Pain Society.  Annals of Internal 
Medicine, 147, 478-491 
 22 
19. Ferguson, R. Robinson, A. & Splaine, M. (2002). Use of the Reliable Change Index to 
evaluate clinical significance in SF-36 outcomes. Quality of Life Research, 11, 509-516 
20. Clinical Standards Advisory Group Committee on Back Pain. (1994). Back pain: report of 
a CSAG committee on back pain. (London: HMSO 
21. The Improvement Network – East Midlands. (n.d.).  The Nottingham Back Team. 
Retrieved Aug 27, 2005 from http://www.tin.nhs.uk/welcome/good-news-stories/back-pain-
team 
22. Ware, J. (2000). SF-36 Health Survey Update. Spine, 25, 3130-3139 
23. Ware, J. Kosinki, M. Bjorner, J. Turner-Bowker, D. Gandek, B and Maruish, M. (2007). 
User’s Manual for the SF-36v2 Health Survey (2nd ed.). (Lincoln, RI: QualityMetric 
Incorporated) 
24. Williams, P. and Nerenz, D. (1995).  When should nonparametric statistics be used to 
analyses f-36 scores?  AHSR FHSR Annu Meet Abstr Book, 12, 152-153 
25. Velanovich, V. (2007). Behaviour and Analysis of sf-36 Short-Form Health Survey Data 
for Surgical Quality-of-Life Research.  Arch Surg, 142, 473-478 
26. Walters, S. and Campbell, M. (2004).  The use of bootstrap methods for analyzing health-
related quality of life outcomes (particularly the SF-36).  Health and Quality of Life 
Outcomes, 2:70 
27. Walters, S. (2004).  Sample size and power estimation for studies with health related 
quality of life outcomes: a comparison of four methods using SF-36.  Health and Quality of 
Life Outcomes, 2:26 
28. Vickers, A. (2005).  Parametric versus non-parametric statistics in the analysis of 
randomized trials with non-normally distributed data.  BMC Medical Research Methodology, 
5:35 
 
 23 
29. Bridge, P. and Sawilowski, S. (1999).  Increasing Physicians’ Awareness of the Impact of 
Statistics on Research Outcomes: Comparative Power of the t-test and Wilcoxon Rank-Sum 
Test in Small Samples Applied Research.  J Clin Epidemiol, 52, 229-235 
30. Hays, R. Brodsky, M. Johnston, M. Spritzer, K. and Hui, K. (2005). Evaluating the 
Statistical Significance of Health-Related Quality-of-Life Change in Individual Patients.  
Eval. Health Prof. 28, 160-171 
31. Bauer, S, Lambert, M. and Nielsen, S. (2004).  Clinical Significance Methods: A 
Comparison of Statistical Techniques.  Journal of Personality Assessment. 82, 60-70 
32. Jenkinson, C. Stewart-Brown, S. Peterson, S. & Paice, C. (1999). Assessment of the SF-
36 version 2 in the United Kingdom. J Epidemiol Community Health, 53, 46-50 
33. Jenkinson, C. Stewart-Brown, S. & Peterson, S. (2005). Assessment and evaluation of the 
SF36 Version II.  Health Services Research Unit.  University of Oxford.  Retrieved July 2 
2005 from http://www.hsru.ox.ac.uk/sf36v2.htm.  
34. Evans, C. Margison, F. & Barkham, M. (1998). The contribution of reliable and clinically 
significant change methods to evidence-based mental health.  Evidence-Based Mental Health, 
1, 70-72 
35. Cella, D. Bullinger, M. Scott, C. and Barofsky, I. (2002). Group vs Individual 
Approaches to Understanding the Clinical Significance of Differences or Changes in Quality 
of Life.  Mayo. Clin. Proc., 77, 384-392 
36. Hoogendoorn, W. Bongers, P. de Vet, H. Twisk, J. van Mechelen, W. & Bouter, L. 
(2002). Comparison of two different approaches for the analysis of data from a prospective 
cohort study: an application to work related risk factors for low back pain. Occup Environ 
Med., 59, 459-465 
37. Vollenbroek-Hutten, M. Hermens, H. Wever, D. Gorter, M. Rinket, J. & Ijzerman, M. 
(2004). Differences in outcome of a multi-disciplinary treatment between subgroups of 
 24 
chronic low back pain patients defined using two multiaxial assessment instruments: the 
Multidimensional Pain Inventory and lumbar dynamometry. Clinical Rehabilitation, 18. 566-
579 
38. Atkins, D. Bedics, J. McGlinchey, J. and Beauchaine, T. (2005). Assessing Clinical 
Significance: Does it Matter Which Method We Use?  Journal of Consulting and Clinical 
Psychology. 73, 982-989 
39. Sloan, J. Cella, D. and Hays, R. (2005).  Clinical significance of patient-reported 
questionnaire data: another step towards consensus. Journal of Clinical Epidemiology. 58, 
1217-1219 
40. Sloan, J. (2003). Practical Guidelines for Assessing the Clinical Significance of Health-
Related Quality of Life Changes within Clinical Trials.  Drug Information Journal. 37, 23-31 
41. Hays, R. and Woolley, J. (2000).  The Concept of Clinically Meaningful Difference in 
Health-Related Quality-of-Life Research – How Meaningful is it?.  Pharmacoeconomics.  18, 
419-423 
42. Jacobson, N. Follette, W. & Revenstorf, D. (1984). Psychotherapy outcome research: 
methods for reporting variability and evaluating clinical significance.  Behaviour Therapy, 
15, 336-352 
43. Jacobson, N. & Truax, P. (1991). Clinical significance: a statistical approach to defining 
meaningful change in psychotherapy research. Journal of Consulting and Clinical 
Psychology, 59, 12-19 
44. Bombardier, C. Hayden, J. & Beaton, D. (2001). Minimal Clinically Important 
Difference. Low back Pain: Outcome Measures.  The Journal of Rheumatology, 28, 431-438 
45. UK Beam Trial Team. (2004). United Kingdom back pain exercise and manipulation (UK 
BEAM) randomised trial: effectiveness of physical treatments for back pain in primary care. 
BMJ, 329, 1377 
 25 
46. Gatchel, R.  Mayer, T. Dersh, J. Robinson, R. & Polatin, P. (1999). The Association of 
the SF-36 Health Status Survey With 1-Year Socioeconomic Outcomes in a Chronically 
Disabled Spinal Disorder Population.  Spine, 24, 2162–2170 
47. Keogh, E. & Herdenfeldt, M. (2002). Gender, coping and the perception of pain. Pain, 97, 
195-201 
48. Dixon, K. Thorn, B. & Ward, L. (2004). An evaluation of sex differences in 
psychological and physiological responses to experimentally-induced pain: a path analytic 
description. Pain, 112, 188-196 
49. Keogh, E. McCracken, L. & Eclestone, C. (2005). Do men and women differ in their 
response to interdisciplinary chronic pain management? Pain, 114, 37-46 
50. McGeary, D. Mayer, T. Gatchel, R. Anagnostis, C. & Proctor, T. (2003). Gender-related 
differences in treatment outcomes for patients with musculoskeletal disorders.  The Spine 
Journal, 3, 197-203 
51. Berkeley, K. (1997). Sex differences in Pain.  Behavioural and Brain Sciences, 20, 371-
380 
52. Ciaramella,  A. Grosso, S. Poli, P. Gioia, A. Inghirami, S. & Massimetti, G. (2004). When 
pain is not fully explained by organic lesion: a psychiatric perspective on chronic pain 
patients. Eur J Pain, 8, 13-22 
53. Crook, J. Milner, R. Schultz, Z. & Stringer, B. (2002). Determinants of occupational 
disability following a low back injury: a critical review of the literature. J Occup Rehabil, 12, 
277-295 
54. Linton, S.  (2000). A review of psychological risk factors in back and neck pain. Spine, 
25, 1148-1156 
 26 
55. Edwards, L. Pearce, S. Turner-Stokes, L. & Jones, A. (1994).  The Pain Beliefs 
Questionnaire: an investigation of beliefs in the causes and consequences of pain.  Pain, 51, 
267-272 
56. Crombez, G. Vlaeyen, J. Heuts, P. & Lysens, R.  Pain-related fear is more disabling than 
pain itself: evidence on the role of pain-related fear in chronic back pain disability. Pain, 80, 
329-339. 
57. Schultz, I. Crook, J. Meloche, G.  Berkowitz, J. Milner, R. & Zuberbier, O. (2004). 
Psychosocial factors predictive of occupational low back disability: towards development of 
a return-to-work model. Pain, 107, 77-85 
58. Baird, A. (2004, April). The impact of pain beliefs and fear avoidant behaviours on 
perceived pain and physical capabilities – a preliminary study.  (Presented at The 37th Pain 
Society Annual Scientific Meeting, Manchester, UK) 
59. Turner, J. Franklin, G. Heagerty, P. Wu, R. Egan, K. Fulton-Kehoe, D. Gluck, J. & 
Wickizer, T. (2004).  The association between pain and disability. Pain, 112, 307–314 
 
 
 27 
Figures 
Figure 1 
0
5
10
15
20
25
30
35
40
45
50
Physical
Function
Role Physical Bodily Pain General Health Vitality Social
Functioning
Role Emotional Mental Health
T
 S
c
o
r
e
 
Figure 1 – SF-36 Health Profile at Assessment of all suitable for the programme 
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Figure 2 – Improvement in health profile from assessment to programme completion (T scores) 
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Tables 
 
Table 1 
SF-36 Scale (T Scores) Non-completers Completers 
Physical Functioning 24 
(15) 
31** 
(12) 
Role-physical 25 
(15) 
32** 
(14) 
Bodily Pain 29 
(10) 
34** 
(10) 
General Health 36 
(10) 
41** 
(10) 
Vitality 38 
(11) 
42* 
(11) 
Social Functioning 35 
(13) 
39* 
(11) 
Role Emotional 34 
(17) 
42** 
(14) 
Mental Health 42 
(13) 
45* 
(10) 
*p < 0.05, **p < 0.01 
Table 1 – Comparison of completers and non-completers 
 
Table 2 
SF-36 Scale (0-100) Assessment Completion Change 
Physical Functioning 31 
(12) 
41 
(12) 
+32%*** 
Role-physical 32 
(14) 
43 
(12) 
+33%*** 
Bodily Pain 34 
(10) 
43 
(11) 
+27%*** 
General Health 41 
(10) 
47 
(10) 
+14%*** 
Vitality 42 
(11) 
49 
(11) 
+18%*** 
Social Functioning 39 
(11) 
47 
(11) 
+20%*** 
Role Emotional 42 
(14) 
48 
(10) 
+16%*** 
Mental Health 45 
(10) 
50 
(11) 
+11%*** 
*** p < 0.000 
Table 2 – Improvement in SF-36 scores from assessment to programme completion 
 
Table 3 
 Males Females All 
Physical Functioning 50% 59% 55% 
Role Physical 56% 55% 55% 
Bodily Pain 37% 43% 40% 
General Health 23% 22% 23% 
Energy/Vitality 33% 31% 32% 
Social Functioning 44% 41% 43% 
Role Emotional 42% 39% 41% 
Mental Health 27% 29% 28% 
Table 3 – Proportion of participants showing clinically significant improvement from assessment to programme 
completion by gender 
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Table 4 
Clinically significant 
change in SF-36 Scale 
Improvement 
from assessment 
to programme 
completion 
Improvement 
from programme 
completion to 
follow-up 
Decline from 
programme 
completion to 
follow-up 
Overall 
improvement from 
assessment to 
follow-up 
Physical Functioning 66% 8% 15% 65% 
Role Physical 63% 15% 17% 70% 
Bodily Pain 46% 6% 13% 49% 
General Health 25% 3% 4% 21% 
Energy/Vitality 34% 8% 7% 38% 
Social Functioning 44% 10% 14% 41% 
Role Emotional 45% 15% 14% 42% 
Mental Health 32% 6% 8% 24% 
Table 4 – Proportion of participants showing clinically significant change 
 
Table 5 
For those showing Proportion (%) also showing clinically significant improvement in: 
CS Improvement in: PF RP BP GH VIT SF RE MH 
Physical Functioning - 83 65 28 46 52 48 33 
Role Physical 76 - 64 26 44 48 52 50 
Bodily Pain 86 91 - 23 51 63 49 29 
General Health 80 80 47 - 60 67 53 47 
Vitality 78 85 67 37 - 59 63 52 
Social Functioning 83 79 76 38 65 - 55 45 
Role Emotion 70 83 57 27 57 50 - 40 
Mental Health 88 71 59 47 82 76 71 - 
Table 5 – Proportion of those showing clinically significant improvement in each scale showing a concurrent 
improvement in other scales 
 
Table 6 
Scale All Suitable CS-PF CS-RP CS-BP 
Physical Functioning 30 27 28 31 
Role-physical 30 29 27 31 
Bodily Pain 32 31 31 31 
General Health 42 43 43 44 
Vitality 42 42 42 43 
Social Functioning 39 37 38 39 
Role Emotional 41 39 40 41 
Mental Health 45 44 45 46 
Table 6 – Comparison of mean scores at assessment 
 
